Hypertension: all 6,834 studies
Page 67 of 69. Open to participants first (971), then studies with results posted, then the rest; newest registration first within each.
- Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 HypertensionCompletedNCT00168779Phase 4
- Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular HypertensionCompletedNCT00168363Phase 3
- LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.CompletedNCT00167869Phase 2
- Ambulatory Blood Pressure Monitoring in HypertensionCompletedNCT00166634Not applicable
- Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese PatientsCompletedNCT00160498Not applicable
- Effects of Potassium Salts on Blood Pressure and Target Organ DamageStatus unknownNCT00160368Phase 3
- Efficacy and Safety of Moxonidine in Indian PatientsCompletedNCT00160277Phase 3
- Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled HypertensionCompletedNCT00160225Phase 2
- Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionCompletedNCT00160212Phase 2
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable
- Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3
- Amlodipine Diabetic Hypertension Efficacy Response TrialCompletedNCT00159692Phase 4
- A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedNCT00159653Phase 3
- Electronic Communications and Home Blood Pressure MonitoringCompletedNCT00158639Phase 3
- A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or PlaceboCompletedNCT00158093Phase 1
- MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)CompletedNCT00157729Phase 2
- Tadalafil in Subjects With Mild to Moderate HypertensionCompletedNCT00157326Phase 2
- Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary HypertensionWithdrawnNCT00155714Not applicable
- Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)CompletedNCT00154271Phase 4
- 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00153049Phase 2
- Effect of Losartan on Retinal Endothelial Function in Patients With Essential HypertensionWithdrawnNCT00152633Phase 2/3
- Salt Reduction on Blood Pressure and Cardiovascular Organ DamageCompletedNCT00152074Phase 3
- Olmesartan Medoxomil in Hypertension and Renal ImpairmentCompletedNCT00151827Phase 3
- Valsartan in Elderly Isolated Systolic Hypertension StudyCompletedNCT00151229Phase 4
- Cognitive/Cerebrovascular Consequences of HTN TreatmentCompletedNCT00151138Not applicable
- Danish Hypertension Prevention Project - DHYPPStatus unknownNCT00150631Phase 3
- To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .CompletedNCT00150358Phase 4
- A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionCompletedNCT00150267Phase 3
- Study on Impact of Patient-Held Guidelines on Blood PressureCompletedNCT00148434Phase 2
- The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 YearsCompletedNCT00147615Phase 3
- A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.CompletedNCT00147589Phase 3
- Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HTCompletedNCT00147563Phase 4
- Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive WomenCompletedNCT00147524Phase 4
- Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mgCompletedNCT00146341Phase 3
- Sildenafil and Pulmonary Artery PressureTerminatedNCT00145938Phase 2
- Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate HypertensionCompletedNCT00145236Phase 3
- Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African AmericansCompletedNCT00145210Phase 3
- Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan MonotherapyCompletedNCT00144222Phase 3
- A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 DiabetesStatus unknownNCT00144144Phase 4
- Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol LevelsCompletedNCT00143234Phase 3
- Adherence to Weight Loss for Hypertension in African American WomenCompletedNCT00142649Not applicable
- CRICKET Study, Coronary Calcium Scores in Patients With Chronic Kidney DiseaseWithdrawnNCT00142636
- Extracellular Fluid in Resistant HypertensionTerminatedNCT00141596Not applicable
- The Renin-Angiotensin System in Essential HypertensionTerminatedNCT00141583Not applicable
- Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)CompletedNCT00140959Phase 4
- ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)CompletedNCT00140907Phase 4
- Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.CompletedNCT00140062Phase 4
- A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaCompletedNCT00140049Phase 4
- Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment GuidanceCompletedNCT00139984Phase 4
- Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential HypertensionCompletedNCT00139698Phase 3
- Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk HypertensionCompletedNCT00139555Phase 4
- Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) TrialCompletedNCT00139386Phase 4
- NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the NewbornCompletedNCT00139217Not applicable
- Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial HypertensionCompletedNCT00138944Phase 3
- L-Arginine Metabolism in Essential HypertensionCompletedNCT00137124Phase 2/3
- Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe HypertensionCompletedNCT00136851Phase 4
- Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive PatientsCompletedNCT00135551Phase 4
- Hypertension in Management of Military MedicineTerminatedNCT00134849
- OlmeSartan and Calcium Antagonists Randomized (OSCAR) StudyCompletedNCT00134160Phase 4
- Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood PressureStatus unknownNCT00133783
- INVEST: INternational VErapamil SR Trandolapril STudyCompletedNCT00133692Phase 4
- The Double Exposure Study: The Impact of Job Strain and Marital Cohesion on Blood PressureCompletedNCT00133653
- A Morbidity-Mortality and Remodeling Study With ValsartanStatus unknownNCT00133328Phase 4
- A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate HypertensionCompletedNCT00133185Phase 3
- Collaboration to Reduce Disparities in HypertensionCompletedNCT00133068Phase 4
- Diuretics In the Management of Essential Hypertension (DIME) StudyCompletedNCT00131846Phase 4
- Recognition of Abnormal Pediatric Blood Pressures in Primary CareCompletedNCT00130663Not applicable
- Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential HypertensionCompletedNCT00130156Phase 4
- STITCH (Simplified Therapeutic Intervention To Control Hypertension)CompletedNCT00129909Phase 4
- Group Visits to Improve Hypertension ManagementCompletedNCT00129493Not applicable
- Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose IntoleranceCompletedNCT00129233Phase 4
- IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering DrugsCompletedNCT00128518Phase 4
- Renal Atherosclerotic Revascularization Evaluation: RAVE StudyCompletedNCT00127738Not applicable
- Effect of Continuous Positive Airway Pressure (CPAP) on Hypertension and Cardiovascular Morbidity-Mortality in Patients With Sleep Apnea and no Daytime SleepinessCompletedNCT00127348Phase 4
- Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive DeclineCompletedNCT00126516Phase 4
- PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00125918Phase 3
- The Effect of Cocoa Flavonoids on Blood PressureCompletedNCT00125866Not applicable
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive PatientsStatus unknownNCT00125463Phase 3
- Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured PatientsTerminatedNCT00125229
- COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And MicroalbuminuriaTerminatedNCT00123903Phase 3
- Rosiglitazone Plaque StudyStatus unknownNCT00123227Phase 3
- Comparison of Two Programs to Improve Blood Pressure Treatment AdherenceCompletedNCT00123058Not applicable
- Patient-Physician Partnership to Improve High Blood Pressure AdherenceCompletedNCT00123045Phase 4
- The Hypertension in the Very Elderly Trial (HYVET)Status unknownNCT00122811Phase 4
- Guidelines for Drug Therapy of Hypertension: Multi-Site ImplementationCompletedNCT00122161Phase 3
- Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)TerminatedNCT00120380Phase 4
- Effectiveness of Home-Based Health Messaging for Patients With Hypertension and DiabetesCompletedNCT00119054Not applicable
- Heart Disease in Sickle Cell AnemiaCompletedNCT00113152
- Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary FibrosisCompletedNCT00109681Phase 2
- Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)CompletedNCT00108017Phase 3
- Internet-based Diabetes Education and Case ManagementCompletedNCT00105898Not applicable
- Study to Lower Veterans BP: Patient/Physician InterventionCompletedNCT00105716Not applicable
- A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
- Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive WomenCompletedNCT00102141Phase 3
- Hypertension Education and Treatment Partnership for Reducing Ethnic Differences in the Risk of Cardiovascular DiseaseCompletedNCT00101504
- Effects of Dark Chocolate on Insulin Sensitivity in People With High Blood PressureCompletedNCT00099476Phase 1
- Endothelial Cell Dysfunction in Pulmonary HypertensionCompletedNCT00098072Phase 1
- Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and ProteinuriaCompletedNCT00097955Phase 2
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3